Jennifer K. Simpson
2020 - Panbela Therapeutics
In 2020, Jennifer K. Simpson earned a total compensation of $1.7M as President and Chief Executive Officer at Panbela Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $78,750 |
|---|---|
| Option Awards | $1,507,025 |
| Salary | $145,587 |
| Total | $1,731,362 |
Simpson received $1.5M in option awards, accounting for 87% of the total pay in 2020.
Simpson also received $78.8K in non-equity incentive plan and $145.6K in salary.
Rankings
In 2020, Jennifer K. Simpson's compensation ranked 6,200th out of 13,090 executives tracked by ExecPay. In other words, Simpson earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,200 out of 13,090 | 53rd |
Division Manufacturing | 2,560 out of 5,620 | 54th |
Major group Chemicals And Allied Products | 1,031 out of 2,253 | 54th |
Industry group Drugs | 890 out of 1,953 | 54th |
Industry Pharmaceutical Preparations | 664 out of 1,458 | 55th |
Source: SEC filing on April 15, 2021.
Simpson's colleagues
We found two more compensation records of executives who worked with Jennifer K. Simpson at Panbela Therapeutics in 2020.
News
Panbela Therapeutics CEO Jennifer Simpson's 2021 pay jumps 372% to $1.2M
April 29, 2022
Panbela Therapeutics CEO Jennifer Simpson's 2020 pay jumps 62% to $1.7M
April 15, 2021
Delcath Systems CEO Gerard Michel's 2020 pay jumps 150% to $5.8M
April 7, 2021
Delcath Systems CEO Jennifer Simpson's 2019 pay jumps 97% to $1.1M
November 2, 2020
Delcath Systems CEO Jennifer Simpson's 2018 pay slips 11% to $542K
August 19, 2019